Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Fox Chase Cancer Center Welcomes Shazia K. Nakhoda
PHILADELPHIA (June 16, 2020) – Fox Chase Cancer Center announces the hiring of Shazia K. Nakhoda, MD, who will join the Department of Hematology/Oncology in the Hematology-Lymphoma Program. Nakhoda will be joining the Fox Chase team upon graduation from the Fox Chase-Temple Hematology/Oncology Fellowship Program.
Nakhoda received her medical degree from the Sidney Kimmel Medical College of Thomas Jefferson University. Nakhoda was an internal medicine resident in the department of medicine at the University of Maryland Medical Center. She is currently a co-investigator in four ongoing research projects at Fox Chase.
Nakhoda is board certified in internal medicine and is a member of the American Society of Clinical Oncology and the American Society of Hematology. She has been published in several peer-reviewed journals and presented at multiple medical meetings.
Nakhoda will begin work at Fox Chase on July 1, 2020.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427